JenaValve
Irvine, California, United States · Biotechnology, Healthcare, Health Care
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surg
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Irvine, California, United States
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- jenavalve.com
- Company page
Recent activity at JenaValve
About JenaValve: questions and answers
What does JenaValve do?
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surg
Where is JenaValve headquartered?
JenaValve is headquartered in Irvine, California, United States.
What is the latest news on JenaValve?
On May 28, 2026, JenaValve Appoints Edward Sarnowski as Chief Technology Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy